International Biotechnology Trust as of June 30, 2018
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 54 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 6.2 | $16M | 164k | 98.23 | |
| Celgene Corporation | 5.8 | $15M | 190k | 79.41 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.4 | $14M | 83k | 169.96 | |
| Illumina (ILMN) | 4.8 | $13M | 45k | 279.29 | |
| Array BioPharma | 4.5 | $12M | 695k | 16.77 | |
| Regeneron Pharmaceuticals (REGN) | 4.2 | $11M | 31k | 344.97 | |
| Biogen Idec (BIIB) | 4.0 | $11M | 36k | 290.27 | |
| Alexion Pharmaceuticals | 3.9 | $10M | 82k | 124.15 | |
| Exelixis (EXEL) | 3.7 | $9.6M | 445k | 21.52 | |
| Adamas Pharmaceuticals | 3.7 | $9.5M | 370k | 25.81 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $9.2M | 97k | 94.20 | |
| Incyte Corporation (INCY) | 3.2 | $8.4M | 126k | 67.01 | |
| D Stemline Therapeutics | 3.0 | $7.9M | 493k | 15.95 | |
| Ligand Pharmaceuticals In (LGND) | 2.8 | $7.2M | 35k | 207.14 | |
| Halozyme Therapeutics (HALO) | 2.8 | $7.2M | 429k | 16.86 | |
| Sage Therapeutics (SAGE) | 2.6 | $6.7M | 43k | 156.43 | |
| Gilead Sciences (GILD) | 2.5 | $6.4M | 90k | 70.85 | |
| Spectrum Pharmaceuticals | 2.4 | $6.3M | 300k | 20.95 | |
| Abiomed | 2.1 | $5.4M | 13k | 409.09 | |
| Ionis Pharmaceuticals (IONS) | 2.0 | $5.3M | 127k | 41.67 | |
| Shire | 1.6 | $4.2M | 25k | 168.80 | |
| Intersect Ent | 1.6 | $4.2M | 112k | 37.40 | |
| Transenterix | 1.5 | $3.8M | 889k | 4.30 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $3.6M | 37k | 98.48 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $3.6M | 27k | 132.15 | |
| Verastem | 1.3 | $3.4M | 500k | 6.87 | |
| Bluebird Bio (BLUE) | 1.2 | $3.1M | 20k | 156.85 | |
| G1 Therapeutics (GTHX) | 1.2 | $3.1M | 72k | 43.35 | |
| Agios Pharmaceuticals (AGIO) | 1.2 | $3.1M | 37k | 84.22 | |
| Deciphera Pharmaceuticals (DCPH) | 1.2 | $3.0M | 77k | 39.32 | |
| Seattle Genetics | 1.1 | $2.8M | 43k | 66.38 | |
| Jazz Pharmaceuticals (JAZZ) | 1.1 | $2.8M | 16k | 172.28 | |
| Madrigal Pharmaceuticals (MDGL) | 1.1 | $2.8M | 10k | 279.00 | |
| Puma Biotechnology (PBYI) | 1.1 | $2.7M | 46k | 59.01 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $2.6M | 322k | 8.10 | |
| Cymabay Therapeutics | 0.8 | $1.9M | 145k | 13.41 | |
| Fibrogen (FGEN) | 0.8 | $2.0M | 31k | 62.52 | |
| Merus N V (MRUS) | 0.7 | $1.7M | 75k | 22.54 | |
| Sangamo Biosciences (SGMO) | 0.6 | $1.6M | 113k | 14.20 | |
| Globus Med Inc cl a (GMED) | 0.6 | $1.5M | 29k | 50.45 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $1.3M | 9.6k | 139.48 | |
| Supernus Pharmaceuticals (SUPN) | 0.5 | $1.3M | 21k | 59.80 | |
| Horizon Pharma | 0.4 | $1.1M | 69k | 16.55 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $1.0M | 370k | 2.82 | |
| Paratek Pharmaceuticals | 0.4 | $1.1M | 104k | 10.15 | |
| Aerie Pharmaceuticals | 0.4 | $998k | 15k | 67.53 | |
| Spark Therapeutics | 0.4 | $992k | 12k | 82.67 | |
| Amicus Therapeutics (FOLD) | 0.3 | $915k | 59k | 15.61 | |
| Portola Pharmaceuticals | 0.3 | $906k | 24k | 37.75 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $892k | 81k | 10.97 | |
| Spring Bk Pharmaceuticals In | 0.3 | $860k | 73k | 11.78 | |
| Viking Therapeutics (VKTX) | 0.3 | $664k | 70k | 9.49 | |
| Radius Health | 0.2 | $554k | 19k | 29.47 | |
| Enteromedics | 0.1 | $121k | 53k | 2.30 |
